Publication | Closed Access

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

OncologyMetronomic TherapyClinical TrialsPharmacotherapyCancer TreatmentMedicineRadiation OncologyHealth Sciences